Robert E. Rydell
26 works · 2,190 citations · h-index 16
Top works
- Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases
- Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia
- Frequent Association of IgMλ with Crystalline Inclusions in Chronic Lymphatic Leukemic Lymphocytes
- Richter's syndrome in chronic lymphocytic leukemia
- Infection in the myelodysplastic syndromes
- Terminal transferase levels in chronic myelogenous leukemia in blast crisis and in remission
- On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
- Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.
- Structure-activity relationships of N-acylarylhydroxylamines in the rat.
- Auer rod positive dysmyelopoietic syndrome
- Lymphoblastic transformation of myelodysplastic syndrome
- Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids.
- Lack of Susceptibility of F344 Rats to Mammary Tumor Induction by Topically Applied Fluorenylacetohydroxamic Acids and Their Acetates 2
- The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
- Malignant Transformation of Rat Embryo Fibroblasts by Carcinogenic Fluorenylhydroxamic Acids In Vitro2
- Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
- Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo.
- Inhibitory Effect of Disulfiram on Rat Mammary Tumor Induction By N-2-Fluorenylacetamide and on its Metabolic Conversion To N-Hydroxy-N-2-fluorenylacetamide2